Ocid

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ocid

What is Ocid? Definition, Class, and Form

The drug Ocid is a common trade name for a medication whose active component is Omeprazole, a potent agent used to effectively control and reduce the production of acid in the stomach. As a prescription-only medication, Ocid is classified within the Proton Pump Inhibitor (PPI) pharmacological class, a designation supported by pharmacological studies. Omeprazole is a synthetic compound derived from the substituted benzimidazole chemical structure, ensuring a predictable and reliable systemic action against hyperacidity.


Quick Facts: Ocid (Omeprazole)

Property Description
Active Ingredient Omeprazole
Form Oral, Delayed-Release Capsules
Pharmacological Class Proton Pump Inhibitor (PPI)
Common Use Reduction of gastric acid secretion
Origin Synthetic, Substituted Benzimidazole

What Type of Medicine is Ocid? (Identity and Classification)

Ocid belongs to the Proton Pump Inhibitor (PPI) class, which signifies that its primary therapeutic function is to block the body's main mechanism for secreting stomach acid. This classification places it among the most effective agents for gastric acid secretion inhibition, a property clinically recognized across numerous pharmacological studies. The drug is classified as a single-ingredient product, operating by targeting the cellular machinery responsible for acid production, thus distinguishing it from substances that merely neutralize existing acid.


Composition and Form: Understanding the Delayed-Release Capsule

The composition of Ocid features Omeprazole as its active ingredient, delivered in the form of an oral, delayed-release capsule. This specialized dosage form is essential because the active compound is highly susceptible to rapid destruction by the strong acid present in the stomach. The capsules contain enteric-coated pellets, which act as a pH-sensitive formulation that ensures the drug remains protected until it passes into the less acidic small intestine, where it can be properly absorbed into the bloodstream.


General Purpose: Why Omeprazole Reduces Stomach Acidity

The general purpose of Ocid is to provide effective and sustained gastric acid secretion inhibition by blocking the final step of acid production. Omeprazole achieves this by targeting and attaching to the proton pump (H+/K+-ATPase enzyme) in the stomach lining, leading to its irreversible inhibition. This robust action provides the core benefit of a significant, long-lasting reduction of acidity, creating a necessary environment for the natural healing of irritated gastrointestinal tissues.

Regulatory References

  1. Omeprazole: MedlinePlus Drug Information

What side effects are possible with Ocid?

Possible Side Effects and Safety Information

The medicine Ocid, whose active substance is Omeprazole, has an officially documented safety profile categorized by how frequently adverse reactions appear and which organ systems they involve. These classifications are defined by government regulatory authorities.


Frequency and System-Organ Classification

The most Common adverse reactions documented in regulatory sources include headache and a range of gastrointestinal disorders such as abdominal pain, nausea, vomiting, diarrhea, constipation, and flatulence. Uncommon effects may involve the nervous system (e.g., dizziness, insomnia) and skin (e.g., rash, dermatitis).

Serious Adverse Reactions

Official labels describe certain rare but serious adverse reactions. These include severe hypersensitivity reactions (e.g., anaphylactic shock), severe skin conditions like Stevens-Johnson syndrome (SJS), and acute kidney inflammation (Acute Tubulointerstitial Nephritis).


Safety Patterns Related to Exposure Duration

Regulatory safety information specifies risks associated with long-term use. Prolonged daily exposure has been formally associated with an increased risk of bone fractures (hip, wrist, or spine) and may lead to deficiencies of Vitamin B-12 and magnesium (Hypomagnesemia).

Safety-Related Restrictions

Official prescribing information defines specific situations where use is restricted. The medicine is formally contraindicated in individuals with a known hypersensitivity to omeprazole or other substituted benzimidazoles. Co-administration with the anti-retroviral drug nelfinavir is also specifically restricted by regulatory documents. Safety considerations are also noted for patients with hepatic impairment, where dose adjustments may be deemed necessary.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents for Omeprazole (Ocid) state that symptoms following over-ingestion are generally mild and reversible. Documented clinical manifestations primarily affect the gastrointestinal system and central nervous system. These include nausea, vomiting, abdominal pain, diarrhea, headache, dry mouth, flushing, somnolence (drowsiness), and lethargy or confusion.

While symptoms are typically transient, high-dose accidental or intentional over-ingestion has been associated with more serious systemic outcomes, such as tachycardia (elevated heart rate) and, in some cases documented by regulators, reversible liver impairment.


Emergency Actions and Management

Regulatory guidance mandates that patients seek immediate medical attention for any suspected overdose and contact a Poison Control Center. Emergency medical care is required if the patient exhibits severe or life-threatening symptoms.

Treatment is defined as symptomatic and supportive, as no specific antidote is known for Omeprazole. The patient should be kept under observation to monitor for potential complications, and hospital monitoring may be required based on the severity of the clinical presentation. Gastric lavage may also be considered by medical professionals if the ingestion is recent.

Therapeutic Uses of Ocid

What Ocid Treats: Main Uses and Benefits

Omeprazole, the active ingredient in Ocid, is considered relevant for symptoms related to inflammatory or irritative states where additional symptomatic support is needed. It is commonly used to help with symptoms related to physical discomfort used in situations involving certain distressing symptoms. “This supportive relief helps maintain a sense of stability when symptoms are more noticeable.”

The medication is considered relevant in conditions characterized by periods of heightened symptoms, including active duodenal and gastric ulcers, Gastroesophageal Reflux Disease (GERD), and erosive esophagitis. It helps improve day-to-day comfort during symptomatic periods in conditions such as GERD, which may assist with symptoms related to physical discomfort like heartburn and acid regurgitation. It is also applied in addressing erosive esophagitis and used in settings marked by temporary physiological imbalance.

Omeprazole is commonly used to help with symptom clusters that may become intense or disruptive, such as those associated with H. pylori when applied in clinical settings that involve acute or unstable symptom patterns. Overall, this supports general well-being during symptomatic phases.

Quick Fact: Relief for Heartburn

Eligibility and Restrictions for Use

Ocid (omeprazole) is generally considered safe and effective for most adults and children over the age of one when prescribed by a healthcare provider. However, its use is contraindicated and requires professional medical review in several circumstances.


Who Should NOT Use Ocid

Condition Reason for Caution/Contraindication
Allergy Known hypersensitivity to omeprazole or any substituted benzimidazoles (e.g., esomeprazole, lansoprazole, pantoprazole).
Specific Drug Interactions Concomitant use with certain medications, such as rilpivirine (for HIV), atazanavir, and nelfinavir, is generally not recommended due to reduced efficacy or increased toxicity of the other drug.
Certain Symptoms Should not be used for immediate heartburn relief, or if experiencing alarming symptoms like difficulty swallowing, unexplained weight loss, or bloody/black stools, as these may mask a serious underlying condition.

Precautions and Special Populations

  • Pregnancy and Breastfeeding: While generally considered safe, use during pregnancy or while breastfeeding should only be initiated after consulting a doctor to weigh potential risks against benefits.
  • Liver Disease: Patients with severe liver impairment may require a lower dose.
  • Long-Term/High-Dose Use: Prolonged therapy may be associated with an increased risk of bone fractures, Clostridium difficile infection, and low Vitamin B12 and magnesium levels. Regular medical monitoring is advised.

What should I know about interactions with other medicines?

Omeprazole, the active ingredient in Ocid, has documented interaction patterns primarily involving metabolic pathways and changes in gastric acidity. Co-administration with certain antiviral medications is officially contraindicated. Regulatory bodies state that Omeprazole must not be used concurrently with Rilpivirine and Nelfinavir, as this combination significantly reduces the plasma concentration of the antivirals, potentially leading to a loss of therapeutic effect.


Omeprazole is documented as an inhibitor of the CYP2C19 enzyme system. This pharmacokinetic interaction is clinically relevant because it reduces the formation of the active metabolite of Clopidogrel, an anti-platelet agent. This inhibitory effect may also increase the systemic exposure (AUC and Cmax) of other CYP2C19 substrates, such as Cilostazol and Diazepam. Patients with hepatic impairment or who are CYP2C19 poor metabolizers may experience heightened exposure effects.


As a gastric acid inhibitor, Omeprazole fundamentally alters the absorption of medicines that require an acidic environment. This action decreases the efficacy of drugs like Atazanavir and Ketoconazole, but conversely may increase the systemic exposure of drugs like Digoxin. Furthermore, regulatory labels advise that treatment with Omeprazole must be temporarily stopped for at least 14 days prior to assessing Chromogranin A ( CgA) levels due to potential interference with diagnostic testing. Herbal products like St. John’s Wort are also restricted for co-use as they may reduce Omeprazole concentrations.

Mechanism of Action

Blocking the Final Common Pathway of Acid Production

This domain covers Omeprazole's action as an irreversible inhibitor of the H^+/K^+-ATPase enzyme , or Proton Pump, which is the cellular machinery responsible for secreting acid into the stomach. The drug creates a covalent bond with the pump, permanently disabling it regardless of the stimuli (e.g., histamine or gastrin) that normally trigger acid release. The creation of this stable bond results in a sustained blockade of enzyme function.


Acid-Catalyzed Activation and Irreversible Binding

The mechanism is unique in that Omeprazole is a pro-drug that must be converted to its active form by the stomach’s acidic environment; it is an activity-dependent inhibitor. Once activated, the irreversible molecular binding sustains the blockade until the parietal cell synthesizes and inserts new proton pumps. This process leads to a significant and sustained rise in intragastric pH (decreased acidity), which is the primary physiological consequence of the mechanism.

Dosage and Administration Information

Official Administration Guidelines for Ocid (Omeprazole)

Ocid is administered via the oral route, primarily as a delayed-release capsule or tablet. The specialized formulation is designed to protect the active component from the highly acidic environment of the stomach, dictating specific rules for administration.


Core Usage Protocol

Feature Official Guideline
Route of Administration Oral; may be administered via nasogastric tube using dispersed contents.
Frequency and Timing Typically taken once daily and must be consumed before eating (e.g., prior to breakfast).
Standard Dosing Adult dosing generally ranges from 20 mg to 40 mg once daily, depending on the specific use, with high doses up to 360 mg/day for certain conditions administered in divided doses.
Course Duration Treatment for acute conditions often follows a prescribed course of 4 to 8 weeks, while long-term regimens are reserved for maintenance and chronic hypersecretory states.

Special Procedural Conditions

To ensure proper function of the delayed-release mechanism, the capsules must be swallowed whole and not crushed, chewed, or split. If an individual is unable to swallow, the enteric-coated pellets may be carefully dispersed into a tablespoon of soft, slightly acidic food, such as applesauce, and swallowed immediately. Dosage adjustment is officially required for individuals with severe hepatic impairment due to altered drug clearance, though generally not required for renal impairment.

Recent Clinical Evidence

Research evidence / Overview of Studies for Ocid (Omeprazole)

The clinical evaluation of Omeprazole (Ocid) has been primarily studied through Randomized Controlled Trials (RCTs), comparative trials, and large meta-analyses reported in scientific and regulatory literature. Research examined outcomes related to systemic or functional imbalance by monitoring objective markers and patient-reported outcomes describing perceived discomfort. Findings describe group patterns and contribute to the broader evidence landscape, but research does not determine whether an individual will respond similarly.


Evidence for Healing and Managing Erosive Esophagitis (EE)

RCTs involving adult populations and defined subgroups of pediatric patients have been used in research exploring how Omeprazole was observed in conditions associated with acute or disruptive episodes, such as Erosive Esophagitis (EE). The primary outcomes measured in these trials were the rates of endoscopic healing of the damaged esophageal lining, typically monitored over short-term periods of 4 to 8 weeks. Research also examined outcomes related to the recurrence of tissue damage over longer maintenance periods, often up to 12 months. Studies reported measurements related to the evolution of healing in the observed populations, and meta-analyses described observed patterns in the lining of the esophagus.

Evidence for Symptom Management in Reflux Disease (GERD)

Research examined Omeprazole in conditions characterized by fluctuating or episodic manifestations like Gastroesophageal Reflux Disease (GERD) through short-term RCTs and systematic reviews. The main outcomes studied included patient-reported outcomes related to physical discomfort (e.g., heartburn and regurgitation) and objective outcomes monitoring physiological strain, such as the duration the stomach's pH level was observed above a certain point. Findings describe patterns observed in these short-term studies, and research describes changes measured during the study period.

What is Still Uncertain About Omeprazole Research

A primary limitation is that many well-controlled trials focused on short-term symptom relief (2 to 8 weeks), meaning there is limited information for long-term outcomes and the sustained patterns of the effect over many years. Furthermore, follow-up durations were limited in controlled maintenance trials, and evidence quality varies across studies when analyzing less common indications or specific subgroups. For instance, the influence of genetic variability on a person's metabolic response to Omeprazole may be related to heterogeneous findings in studies exploring symptom intensity or variability.

Key Studies & References

  1. Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants - Clinical and Experimental Pediatrics

Frequently Asked Questions (FAQ)

Common questions about Ocid (FAQ)

Q: What conditions does Ocid treat besides heartburn?

According to official product information, Ocid (Omeprazole) is also indicated for the treatment of various other acid-related conditions. These include Duodenal and Gastric ulcers, Erosive Esophagitis (damage to the food pipe from acid), and certain Pathological Hypersecretory conditions, such as Zollinger-Ellison Syndrome.

Q: Does Ocid help with H. pylori infections?

Regulatory documents indicate that Ocid is approved as part of a specific combination regimen with antibiotics. This combination is used to eradicate the Helicobacter pylori bacteria, which helps reduce the risk of peptic ulcers returning.

Q: How soon after starting Ocid do people typically notice an improvement?

Official information states that Ocid's full acid-reducing effect is usually reached after four days of taking it once daily. However, many people may begin to notice some symptom relief within the first 24 hours after taking the initial dose.

Q: Does Ocid work instantly like some other heartburn medicines?

Omeprazole is a pro-drug, meaning it needs time to be activated by stomach acid before it can begin working. Because its full acid-blocking effect is gradual, its onset of effect is not instantaneous, unlike medications that only neutralize existing acid. Other types of acid reducers, known as H2 blockers, may also start working faster.

Q: Can I stop taking Ocid suddenly, or is a gradual approach described?

Official documents state that the decision to discontinue treatment should be reviewed by a healthcare professional. Although explicit tapering instructions are not provided in the label, users often report a temporary return of symptoms, sometimes called rebound acid hypersecretion, when they stop suddenly.

Q: Is dry mouth a known side effect when using Ocid?

Core regulatory safety sections list the most commonly reported side effects, which focus on gastrointestinal issues, nausea, and headache. Dry mouth is not listed among the most Common or Uncommon adverse effects in this official safety information.

Q: Why do some people feel more gassy when taking Ocid?

Flatulence (gassiness) and abdominal pain are officially listed as Common side effects of Ocid. This effect is described as related to the drug's action of reducing stomach acid, which may influence digestive processes.

Q: Can Ocid be taken at the same time as pain relievers like ibuprofen or aspirin?

Regulatory information notes that Ocid is indicated for reducing the risk of gastric ulcers associated with continuous use of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen or aspirin. Separate warnings exist regarding the concurrent use of Ocid with the anti-platelet agent Clopidogrel.

Q: Is it generally considered appropriate to take Ocid while taking a thyroid medication?

Studies indicate that Omeprazole can reduce the body's absorption of levothyroxine, a common thyroid medicine. Official information indicates that healthcare providers may need to monitor thyroid hormone levels more frequently when both medications are used together.

Q: What is the guidance on using Ocid while also consuming alcohol?

Core regulatory information states there is generally no direct interaction between Omeprazole and alcohol itself. However, because alcohol naturally increases stomach acid production and can relax the lower esophageal valve, alcohol consumption may counteract the beneficial effects of the medication.

Q: Is Ocid's mechanism of action different from a Histamine H2 blocker?

Yes, the two drug types work in different ways to reduce acid. Omeprazole belongs to the PPI class, which works by irreversibly blocking the proton pump, the final step of acid secretion. H2 blockers, in contrast, work by blocking histamine receptors on the cells that produce acid.

Q: Is a metallic taste in the mouth a reported side effect of Ocid?

Core regulatory safety information classifies side effects by how often they occur. A metallic taste or any other significant taste disturbance is not listed among the most Common or Uncommon adverse effects in the official product information.

Q: Does Ocid need to be separated in time from iron supplements?

Since Ocid reduces stomach acidity, it can interfere with the body's ability to properly absorb compounds that require an acidic environment, such as iron salts. Therefore, some healthcare professionals describe separating the administration of Ocid and iron supplements to support the body's absorption of the iron.

Q: Is Ocid commonly used by elderly patients?

Official regulatory documents generally do not require a special dose adjustment solely based on age for older patients. However, long-term use in older adults is specifically mentioned in relation to an increased potential risk for side effects like bone fractures and vitamin deficiencies.

Q: What is the information regarding Ocid use during pregnancy or breastfeeding?

Official regulatory information states that the use of Omeprazole during pregnancy is considered after a professional assessment to weigh potential risks against potential benefits. Because Omeprazole is excreted into human milk, official guidelines describe a general recommendation against its use during breastfeeding due to potential effects on the nursing infant.

Q: Is Ocid the same kind of medicine as Zantac or Prilosec?

Ocid contains the active ingredient Omeprazole, which is the same as the active ingredient in Prilosec. However, it is important to note that Zantac (ranitidine) is a different type of drug belonging to the Histamine H2 blocker class, which works through a different mechanism than Omeprazole.

Q: Have there been studies on the long-term safety of Ocid use?

Regulatory safety information explicitly specifies risks associated with long-term use, including bone fractures and deficiencies of Vitamin B-12 and magnesium. However, the accompanying research documents note that many well-controlled trials focus on short-term efficacy (typically 2 to 8 weeks), meaning there is limited long-term data from controlled studies.

How should Ocid be stored and disposed of?

How to Store and Dispose of Ocid (Omeprazole)

Official regulatory documents define strict requirements for storing and disposing of this medication to maintain its stability.

Storage Requirements

Condition Requirement
Temperature Store below 25 C or 30 C (varies by formulation)
Protection Must be protected from light and moisture
Packaging Keep in the original container and ensure it is tightly closed
Stability Use within 100 days after first opening for certain bottle presentations

Handling and Disposal

All omeprazole products must be stored out of the reach of children. Unused or expired medication should be disposed of in accordance with local regulations. The preferred method is typically through a local drug take-back program or authorized collection site. To protect the environment, do not dispose of the medication by pouring it down a drain or flushing it down a toilet unless specifically instructed to do so by the manufacturer's label or a regulatory agency.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ocid found in:

A-Z Index: